You are here
Neo Synth presents the Annual Precision: Lung Cancer World Summit taking place on July 25-26 2017 in Boston, USA
Over the two days, this exclusive summit will bring together will bring together senior scientists and business leaders from pharma, biotech and academia, using extensive networking sessions to forge meaningful collaborations.
Lung cancer R&D is experiencing rapid growth, representing an enormous opportunity for drug developers, with a recent 22% rise in new candidates.
The summit will cover the latest updates from the pipelines of small and large drug developers, and feature discussions around the latest trends in precision medicine through case studies from early discovery to development.
Speaker Organizations Include: Merck, AstraZeneca, Janssen, Novartis, Takeda etc.
Topics Include: Immuno-Oncology, Biomarkers / Companion Diagnostics, Liquid Biopsy, etc.